Preora Diagnostics to Commercialize Cancer Pre-screening Tests

NanoCytomics LLC today announced the formation of Preora Diagnostics Inc., a privately held medical technology company that will bring low-cost cancer pre-screening tests to primary care physicians in the U.S. and other select markets.

Click here to read the full story.

Preora Launch Release